Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Candel Therapeutics, Inc. | 111,349 | reported | 25 Jun 2025 | tx 12+630,823−696,851 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Jun 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 111,349 | 4.67 USD | |
| 17 Jun 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 14,240 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Candel Therapeutics, Inc. | 14,240 | 0.00 USD | deriv |
| 28 Jun 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 14,240 | 0.00 USD | deriv |
| 08 Dec 2022 | PURCHASE | Candel Therapeutics, Inc. | 3,050 | 1.68 USD | first after silence |
| 09 Dec 2022 | PURCHASE | Candel Therapeutics, Inc. | 23,950 | 1.92 USD | |
| 13 Oct 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 14,240 | 0.00 USD | deriv |
| 29 Jul 2021 | CONVERSION | Candel Therapeutics, Inc. | 283,514 | — | |
| 29 Jul 2021 | PURCHASE | Candel Therapeutics, Inc. | 125,000 | 8.00 USD | |
| 29 Jul 2021 | CONVERSION | Candel Therapeutics, Inc. | 696,851 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 08 Dec 2022.